K

Kangji Medical Holdings Ltd
HKEX:9997

Watchlist Manager
Kangji Medical Holdings Ltd
HKEX:9997
Watchlist
Price: 6.4 HKD 0.47%
Market Cap: 7.6B HKD
Have any thoughts about
Kangji Medical Holdings Ltd?
Write Note

Kangji Medical Holdings Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kangji Medical Holdings Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
K
Kangji Medical Holdings Ltd
HKEX:9997
Pre-Tax Income
ÂĄ588.8m
CAGR 3-Years
24%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Pre-Tax Income
ÂĄ2.3B
CAGR 3-Years
-8%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Pre-Tax Income
ÂĄ1.1B
CAGR 3-Years
14%
CAGR 5-Years
15%
CAGR 10-Years
21%
Autobio Diagnostics Co Ltd
SSE:603658
Pre-Tax Income
ÂĄ1.4B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Pre-Tax Income
ÂĄ749.8m
CAGR 3-Years
-45%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Pre-Tax Income
ÂĄ1.9B
CAGR 3-Years
20%
CAGR 5-Years
19%
CAGR 10-Years
N/A
No Stocks Found

Kangji Medical Holdings Ltd
Glance View

Market Cap
7.8B HKD
Industry
Health Care

Kangji Medical Holdings Ltd., nestled in the bustling backdrop of China's thriving medical device industry, has carved a niche for itself in the realm of minimally invasive surgery (MIS). Since its inception, the company has focused on designing and manufacturing a range of surgical tools and devices that cater specifically to MIS procedures. These procedures, which include general surgery, gynecology, and urology, are gaining popularity due to their reduced recovery times and lower risk factors compared to traditional surgery. Kangji Medical leverages its robust R&D capabilities and intimate understanding of physicians' needs to deliver high-quality, ergonomic instruments that enhance operational precision and patient outcomes. The lifeblood of Kangji Medical lies in its strategic manufacturing and marketing prowess, enabling it to maintain a solid foothold in the competitive landscape. By keeping its production chain streamlined and efficient, the company achieves significant cost advantages, which in turn translates to competitive pricing. These savings are reinvested in expanding its product portfolio and enhancing technological innovations, thus ensuring a constant edge over its peers. Moreover, Kangji's astute distribution networks and partnerships with leading hospitals enable it to secure a steady demand flow for its products. This strategy has not only facilitated steady revenue growth but also ensured Kangji's reputation as a reliable contributor to the advancing field of minimally invasive surgical procedures.

Intrinsic Value
10.32 HKD
Undervaluation 38%
Intrinsic Value
Price
K

See Also

What is Kangji Medical Holdings Ltd's Pre-Tax Income?
Pre-Tax Income
588.8m CNY

Based on the financial report for Dec 31, 2023, Kangji Medical Holdings Ltd's Pre-Tax Income amounts to 588.8m CNY.

What is Kangji Medical Holdings Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
18%

Over the last year, the Pre-Tax Income growth was 5%. The average annual Pre-Tax Income growth rates for Kangji Medical Holdings Ltd have been 24% over the past three years , 18% over the past five years .

Back to Top